Monday, August 1, 2016
Sorrento Therapeutics Names New Board Member
San Diego-based biopharmaceuticals developer Sorrento Therapeutics announced this morning that it has named Dr. Yue Alexander Wu to its board of directors. Wu is co-founder, President, Chief Executive Officer and Chief Scientific Officer of Crown Bioscience International. He also served at Starvax Inernational and Burrill 7 Company as an investment banker. The copany said Wu replaces Doug Ebersole, who resigned from the company's board due to personal reasons.